Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17106164 | 1.00 | BRD4 (0.42) | BRD4TP53CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL18733368 | 0.85 | BRD4 (0.40) | BRD4TP53CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL17106233 | 0.81 | HRH3 (0.39) | PDK1ALDH1A1KMT2A | |
| SCHEMBL14074244 | 0.81 | PDK1 (0.50) | PDK1ALDH1A1KMT2A | |
| SCHEMBL31009629 | 0.81 | PDK1 (0.50) | PDK1ALDH1A1KMT2A | |
| SCHEMBL28101740 | 0.81 | PDK1 (0.50) | PDK1ALDH1A1KMT2A | |
| SCHEMBL17106361 | 0.79 | CHRNA1 (0.33) | CHRNB2CHRNA4CHRNB4CHRNA3PDK1 | |
| SCHEMBL17106367 | 0.79 | CHRNA1 (0.33) | CHRNB2CHRNA4CHRNB4CHRNA3PDK1 | |
| SCHEMBL17106364 | 0.79 | CHRNA1 (0.33) | CHRNB2CHRNA4CHRNB4CHRNA3PDK1 | |
| SCHEMBL4868550 | 0.78 | BRD4 (0.47) | BRD4TP53CHRNB2CHRNA4CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| EP-3122847-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2019-05-15 | — | — | EP | disclosed |
| EP-2928996-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-2928996-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-04-11 | — | — | EP | disclosed |
| EP-2928997-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2017-01-25 | — | — | EP | disclosed |
| EP-2928997-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2017-01-25 | — | — | EP | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160289593-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-10-06 | — | — | US | disclosed |
| US-9303232-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-9303232-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-20150267143-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2015-09-24 | — | — | US | disclosed |
| US-20150267143-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2015-09-24 | — | — | US | disclosed |
| US-20140161740-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| US-20140161741-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| US-20140161741-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| US-20140161740-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| WO-2014089253-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014089253-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014089254-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014089254-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289593-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | BRD4 4741/4885TP53 1051/4885CHRNB2 822/4885 |
| US-20150267143-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | BRD4 4741/4885TP53 1051/4885CHRNB2 822/4885 |
| US-20140161741-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | BRD4 4741/4885TP53 1051/4885CHRNB2 822/4885 |
| US-20140161740-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | BRD4 4741/4885TP53 1051/4885CHRNB2 822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.